EGFR and glioma: Taken together, findings obtained in the current study demonstrate that glioma cells-derived exosomal miR-148a-3p activate the EGFR/MAPK signaling pathway by repressing the expression of the ERRFI1 gene, leading to the promotion of tumor angiogenesis in glioma.